5 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results ... #NEJM #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Fremanezumab for ... to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Six Trials of Patent Foramen Ovale Closure for Stroke with Results Published in the Journal. #EBM
for Stroke with Results ... #EBM #Neuro #Cardiology ... EvidenceSummary #Table #NEJM
Hemolysis in Hereditary Spherocytosis. Panel A shows the structure of a normal red cell and a
and cytoskeleton results ... Pathophysiology #Honc ... #IM #Spherocytosis ... HereditarySpherocytosis #NEJM